Canada markets closed

CSPC Pharmaceutical Group Limited (CVG.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
1.0450+0.0025 (+0.24%)
At close: 08:04AM CET
Currency in EUR

Valuation Measures4

Market Cap (intraday) 13.17B
Enterprise Value 11.45B
Trailing P/E 17.09
Forward P/E 14.33
PEG Ratio (5 yr expected) 2.53
Price/Sales (ttm)3.17
Price/Book (mrq)3.36
Enterprise Value/Revenue 0.39
Enterprise Value/EBITDA 1.65

Trading Information

Stock Price History

Beta (5Y Monthly) 0.75
52-Week Change 31.46%
S&P500 52-Week Change 3-6.78%
52 Week High 31.2535
52 Week Low 30.8368
50-Day Moving Average 31.0484
200-Day Moving Average 31.0019

Share Statistics

Avg Vol (3 month) 31.3k
Avg Vol (10 day) 31.08k
Shares Outstanding 511.93B
Implied Shares Outstanding 6N/A
Float 88.36B
% Held by Insiders 129.56%
% Held by Institutions 134.33%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 40.03
Forward Annual Dividend Yield 42.56%
Trailing Annual Dividend Rate 30.24
Trailing Annual Dividend Yield 322.73%
5 Year Average Dividend Yield 41.50
Payout Ratio 432.80%
Dividend Date 3N/A
Ex-Dividend Date 4Sept 08, 2022
Last Split Factor 28:5
Last Split Date 3Oct 16, 2020

Financial Highlights

Currency in CNY.

Fiscal Year

Fiscal Year Ends Dec 31, 2021
Most Recent Quarter (mrq)Sept 30, 2022

Profitability

Profit Margin 18.68%
Operating Margin (ttm)22.14%

Management Effectiveness

Return on Assets (ttm)N/A
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)30.72B
Revenue Per Share (ttm)2.58
Quarterly Revenue Growth (yoy)15.60%
Gross Profit (ttm)21.14B
EBITDA 7.56B
Net Income Avi to Common (ttm)5.74B
Diluted EPS (ttm)0.0600
Quarterly Earnings Growth (yoy)18.00%

Balance Sheet

Total Cash (mrq)13.97B
Total Cash Per Share (mrq)1.17
Total Debt (mrq)682.56M
Total Debt/Equity (mrq)2.32
Current Ratio (mrq)N/A
Book Value Per Share (mrq)2.35

Cash Flow Statement

Operating Cash Flow (ttm)N/A
Levered Free Cash Flow (ttm)N/A